Anne Kim
Lawyers
Filters
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
DXC Technology €650 million senior notes offering
We advised the initial purchasers on the investment-grade debt offering
Esperion Therapeutics follow-on offering
The shares are listed on Nasdaq
Neptune $368 million IPO
The shares are listed on the New York Stock Exchange
Somnigroup International $953 million secondary offering
The shares are listed on the New York Stock Exchange
General Motors $2 billion senior notes offering
The investment-grade notes offering consists of three tranches
AbbVie $4 billion senior notes offering
The investment-grade notes are due 2028, 2030, 2035 and 2055
SailPoint $1.4 billion IPO
The shares are listed on the Nasdaq Global Select Market
Genius Sports $150 million follow-on offering
The shares are listed on the NYSE
Arcos Dorados renewal of long-term master franchise agreement with McDonald’s
We advised Arcos Dorados on the transaction